COVID-19

Tackling coronavirus: why T-cells and antibodies are better together

The #COVID19 vaccine developed by the Oxford University’s Jenner Institute and Oxford Vaccine Group – funded by UK Research and Innovation’s Medical Research Council and the National Institute for Health Research – made headlines when the results of early stage trials revealed that it produces strong immune response and shows no early safety concerns.

Volunteers given the vaccine showed strong T-cell and antibody responses against the #coronavirus SARS-CoV-2.

Help us spread the science behind #coronavirus. #vaccine #immunity

More in our COVID-19 science playlist :

Our research tackling Covid-19 playlist:

NEWSLETTER ✉️
Sign up to our weekly newsletter for the latest updates.

CONNECT WITH US 📲
Keep in touch via our social channels!

Twitter ➤
Facebook ➤
LinkedIn ➤
YouTube ➤
___________________________________________
UKRI supports world-leading research and innovation to push the frontiers of human knowledge and generate social, cultural and economic impact. Learn more here: www.ukri.org/about-us/